Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04423068 · ClinicalTrials.gov registry record · Early Phase 1
Inpatient Adolescent Contraception
A Early Phase 1 study of Pregnancy and Pregnancy Related, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT04423068: Completed Early Phase 1 study of Pregnancy and Pregnancy Related, sponsored by Children's Mercy Hospital Kansas City.
NCT04423068 is a Early Phase 1 study of Pregnancy and Pregnancy Related that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 25 participants, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04423068, a Early Phase 1 study of Pregnancy and Pregnancy Related, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this study is to refine and pilot test the investigators novel intervention to offer contraception counseling and initiation for hospitalized female adolescents, focusing on long acting reversible contraception (LARC).
Primary Outcome
The investigators primary outcome is feasibility of the intervention among female adolescent participants, which the investigators will assess by administering a survey with 12 Likert-type items with responses ranging from 0 (strongly disagree) to 4 (strongly agree). The midpoint (neutral) point on the 0-4 scale is 2, and the investigators define "acceptable level of feasibility" as the median feasibility rating in the population exceeding 2.5, meaning at least half the ratings are positive. Thu
Conditions Studied
Interventions
- BEHAVIORAL SexHealth II
- DRUG Contraceptive
Study Locations (1)
Missouri
- Children's Mercy Hospitals and Clinics - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2020-12-10 |
| Est. Completion | 2023-04-04 |
| Phase | Early Phase 1 |
What the finished NCT04423068 record still lists
NCT04423068 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (97% lower).
The record links to 5 conditions, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which SexHealth II is the first listed.
NCT04423068 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04423068 about?
NCT04423068 is a clinical study titled "Inpatient Adolescent Contraception". The overall goal of this study is to refine and pilot test the investigators novel intervention to offer contraception counseling and initiation for hospitalized female adolescents, focusing on long acting reversible contraception (LARC).
What is the current status of trial NCT04423068?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 25 participants. The study started on 2020-12-10. Estimated completion is 2023-04-04.
What conditions does trial NCT04423068 study?
This clinical trial studies the following conditions: Pregnancy, Pregnancy Related, Contraception, Contraceptive Usage, Contraception Behavior.
What interventions are being tested in trial NCT04423068?
The interventions under investigation include: SexHealth II (BEHAVIORAL), Contraceptive (DRUG).
Who is sponsoring clinical trial NCT04423068?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04423068 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04423068's enrollment target sits among peer trials
25 176th of 191 higher than 14 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Induction of Labor in Morbidly Obese Patients
RECRUITING · Early Phase 1
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI